Research output per year
Research output per year
Personal profile
Ancillary activities
- Satyagraha Holding B.V. | Den Haag | Directeur/eigenaar | 2013-06-05 - present
Ancillary activities are updated daily
Personal information
Kenneth Fernald (1987) obtained his PhD in Management and Economics from the Erasmus Research Institute of Management (ERIM). Specializing in the dynamic fields of venture capital, strategic alliances, mergers & acquisitions, and governance, his research focuses on innovation within the Life Sciences sector. Kenneth spearheads courses for master's students in Entrepreneurship and Finance, tailored to the Health and Life Sciences. Beyond his academic pursuits, he brings over a decade of invaluable experience as a consultant and entrepreneur, blending practical industry insights with academic expertise.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Kenneth Fernald is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Upscaling vaccine manufacturing capacity - key bottlenecks and lessons learned
Feddema, J. J., Fernald, K. D. S., Schikan, H. G. C. P. & van de Burgwal, L. H. M., 5 Jul 2023, In: Vaccine. 41, 30, p. 4359-4368 10 p.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access -
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance
Fernald, K. D. S., Pennings, H. P. G., van den Bosch, J. F., Commandeur, H. R. & Claassen, H. J. H. M., 23 Feb 2017, In: PLoS ONE. 12, 2, p. e0172488 e0172488.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access -
Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation
Fernald, K. D. S., Pennings, H. P. G. & Claassen, E., Nov 2015, In: Journal of Product Innovation Management. 32, 6, p. 971-996 26 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Trade-sale exits in different biotech sectors
Fernald, K. D. S. & Claassen, E., 2015, In: Nature Biotechnology. 33, p. 1221-1239Research output: Contribution to Journal › Article › Academic › peer-review
-
Venture capitalists as gatekeepers for biotechnological innovation
Fernald, K., Hoeben, R. & Claassen, H. J. H. M., 1 Jul 2015, In: Journal of Commercial Biotechnology. 21, 3, p. 32-41 10 p.Research output: Contribution to Journal › Article › Academic › peer-review